SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

NRx Pharmaceuticals Q3 net loss narrows 63% to $2.2 million

NRx Pharmaceuticals Q3 net loss narrows 63% to $2.2 million NRx Pharmaceuticals’ third-quarter 2

NRXP

Related stories